Elsevier

Progress in Neurobiology

Volume 176, May 2019, Pages 86-102
Progress in Neurobiology

Review article
Sex differences in depression: Insights from clinical and preclinical studies

https://doi.org/10.1016/j.pneurobio.2019.01.006Get rights and content

Highlights

  • Women are more likely than men to present with depression.

  • Women are more likely to present with comorbid anxiety and somatic symptoms.

  • Sex hormones may be an effective adjuvant therapy.

  • Sex differences exist in neurobiological, immune, and transcriptional signatures.

  • The postpartum is a time of greatest risk for depression in women's lifetime.

Abstract

Depression represents a global mental health concern, and disproportionally affects women as they are twice more likely to be diagnosed than men. In this review, we provide a summary of evidence to support the notion that differences in depression between men and women span multiple facets of the disease, including epidemiology, symptomology, treatment, and pathophysiology. Through a lens of biological sex, we overview depression-related transcriptional patterns, changes in neuroanatomy and neuroplasticity, and immune signatures. We acknowledge the unique physiological and behavioral demands of pregnancy and motherhood by devoting special attention to depression occurring in the peripartum period. Specifically, we discuss issues surrounding the presentation, time course, treatment, and neurobiology of peripartum depression. We write this review with the intention of highlighting the encouraging advancements in our understanding of sex differences in depression, while underscoring the gaps that remain. A more systematic consideration of biological sex as a variable in depression research will be critical in the discovery and development of pharmacotherapies that are efficacious for both men and women.

Section snippets

Sex differences in clinical presentation, comorbidities, and antidepressant efficacy

Depression is a heterogeneous disorder whereby clinical presentation and symptomology varies between affected individuals (Rush, 2007). There is evidence that biological sex is a factor that can explain at least some of the variability in depression presentation and comorbidities. For example, various reports indicate that compared to men, women with depression are more likely to experience higher symptom severity (Marcus et al., 2008, Marcus et al., 2005), and the sexes show differences in the

Potential sex differences in the etiology and pathophysiology of depression

Depression is a complex disorder with substantial heterogeneity in etiology and pathophysiology. Several theories have been posited to explain the mechanisms underlying depression, including dysfunction or alterations in monoamine neurotransmitter systems (Delgado, 2000, Hirschfeld, 2000), the glutamatergic system (Sanacora et al., 2012), stress response systems (Gold, 2015), sex steroids (Bloch et al., 2003), neuropeptides (Kormos and Gaszner, 2013, Morales-Medina et al., 2010) neuroplasticity

Sex differences in anatomical brain abnormalities in depression

Individuals with depression present with anatomical abnormalities and dysregulated network connectivity in limbic regions (Drysdale et al., 2017, Greicius et al., 2007, Koolschijn et al., 2009, Lorenzetti et al., 2009, Schmaal et al., 2016). Morphological alterations to the hippocampus are perhaps the most extensively studied in relation to depression, with several reports of reduced hippocampal volume, an effect which is corroborated by meta-analyses (McKinnon et al., 2009, Schmaal et al., 2016

Sex differences in the effects of stress exposure or antidepressant treatment on adult hippocampal neurogenesis and dendritic remodeling

The hippocampus maintains the ability to produce new neurons throughout life in many species including humans (Boldrini et al., 2018, Eriksson et al., 1998, Gould et al., 1999), and evidence points to a role of neurogenesis in emotional processing (Anacker and Hen, 2017) and the neuroendocrine stress response (Surget et al., 2011). Reduced hippocampal neurogenesis is observed in animal models of depression (Bessa et al., 2009, Brummelte and Galea, 2010a, Brummelte and Galea, 2010b, David et

Sex difference in the transcriptional signature of depression

The success of genome-wide association studies (GWAS) in identifying genetic loci that significantly contribute to depression susceptibility has been generally limited (Consortium, 2015, Flint and Kendler, 2014, Hyde et al., 2016), highlighting the genetic heterogeneity of the disorder, and the role of environmental influences. On the other hand, there is emerging evidence indicating that depression-related changes in gene expression are sex-specific (Gray et al., 2015, Labonté et al., 2017,

Sex differences in immune dysregulation in depression and its models

There is ample evidence in support of the involvement of the immune system in depression (reviewed in Miller and Raison, 2016), and a subpopulation of individuals with depression display increased circulating concentrations of pro-inflammatory markers (meta-analyses: (Dowlati et al., 2010, Haapakoski et al., 2015)), and elevated markers of neuroinflammation (Rao et al., 2010, Setiawan et al., 2015, Steiner et al., 2008). Further, there is no shortage of evidence linking inflammation to

Sex hormones in depression and its treatment

Sex differences in depression point to a role of sex hormones in the disease mechanisms. Indeed, both androgens in men and estrogens in women have been implicated in depression and its treatment. In men, hypogonadism is associated with depression (McIntyre et al., 2006, Shores et al., 2005, Westley et al., 2015), and testosterone replacement therapies show some efficacy in alleviating depression, particularly in hypogonadal men (Seidman and Rabkin, 1998, Shores et al., 2009, Zarrouf et al., 2009

Depression during pregnancy and the postpartum period: female-unique factors in the susceptibility for depression

Pregnancy and motherhood place unique physiological and behavioral demands on the females of most mammalian species, including humans. The peripartum period also represents a time of increased susceptibility to mood disorders in a women's life, with an estimated 15% of women developing depression during the perinatal period (O’Hara and Swain, 1996). Below, we discuss issues surrounding the presentation, time course, and treatment of perinatal depression (PND). We also review neurobiological

Distinguishing postpartum depression from major depression

Currently, the DSM-5 defines depression in mothers under Major Depressive Disorder (MDD), with peripartum onset as a specifier; this includes all the diagnostic criteria of MDD but occurring during pregnancy or within the first four weeks of giving birth (American Psychiatric Association, 2013). However, there are several issues with this definition. First, this definition does not categorize depression during antepartum versus during the postpartum as separate subtypes of MDD, and it does not

Neurobiology of motherhood & PPD

During pregnancy, total brain volume shrinks by 8% and returns to pre-conception volume within 6 months postpartum (Oatridge et al., 2002). A recent study showed pre- to post-pregnancy reductions in gray matter volume in areas such as the anterior cingulate cortex, bilateral temporal cortex, inferior frontal cortex, and the hippocampus, and these reductions were correlated with maternal-infant attachment (Hoekzema et al., 2017). The reductions in gray matter volume were still evident 2 years

Issues surrounding PPD treatment

As in the case of MDD, mothers suffering from depression during pregnancy and postpartum are also prescribed antidepressants such as SSRIs. However, there is emerging clinical evidence indicating that these prescribed antidepressants have limited efficacy during gestation or in the postpartum (systematic review: De Crescenzo et al., 2014). One clinical trial found that SSRI treatment reduced depressive scores 4 weeks into the intervention period in comparison to counseling, but this effect was

Conclusions

It is evident from the preceding review of the literature that there are notable sex differences in depression-related gene expression, neuroplasticity, and immune signatures; these differences may account for disparities in prevalence and pathoetiology of the disease between men and women. There are sex differences reported in other biomarkers of depression (e.g. BDNF, nerve growth factor, serotonin, and dopamine), and in genetic polymorphisms associated with risk for depression, but these are

References (270)

  • E.Q. Cox et al.

    Oxytocin and HPA stress axis reactivity in postpartum women

    Psychoneuroendocrinology

    (2015)
  • M. Darnaudéry et al.

    Early motherhood in rats is associated with a modification of hippocampal function

    Psychoneuroendocrinology

    (2007)
  • D.J. David et al.

    Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression

    Neuron

    (2009)
  • F. De Crescenzo et al.

    Selective serotonin reuptake inhibitors (SSRIs) for post-partum depression (PPD): a systematic review of randomized clinical trials

    J. Affect. Disord.

    (2014)
  • P.H. Desan et al.

    Monoamine neurotransmitters and metabolites during the estrous cycle, pregnancy, and the postpartum period

    Pharmacol. Biochem. Behav.

    (1988)
  • Y. Dowlati et al.

    A meta-analysis of cytokines in major depression

    Biol. Psychiatry

    (2010)
  • H. Engler et al.

    Men and women differ in inflammatory and neuroendocrine responses to endotoxin but not in the severity of sickness symptoms

    Brain. Behav. Immun.

    (2016)
  • E.M. Falconer et al.

    Sex differences in cell proliferation, cell death and defensive behavior following acute predator odor stress in adult rats

    Brain Res.

    (2003)
  • A. Fernández-Guasti et al.

    Sex and age differences in the antidepressant-like effect of fluoxetine in the forced swim test

    Pharmacol. Biochem. Behav.

    (2017)
  • S.D. Fisher et al.

    Factors associated with onset timing, symptoms, and severity of depression identified in the postpartum period

    J. Affect. Disord.

    (2016)
  • V.G. Frokjaer et al.

    Role of serotonin transporter changes in depressive responses to sex-steroid hormone manipulation: a positron emission tomography study

    Biol. Psychiatry

    (2015)
  • L.A. Galea et al.

    Estradiol alleviates depressive-like symptoms in a novel animal model of post-partum depression

    Behav. Brain Res.

    (2001)
  • L.A.M. Galea et al.

    Sex differences in dendritic atrophy of CA3 pyramidal neurons in response to chronic restraint stress

    Neuroscience

    (1997)
  • J.E. Garrett et al.

    Chronic stress effects on dendritic morphology in medial prefrontal cortex: sex differences and estrogen dependence

    Neuroscience

    (2009)
  • M. Gemmel et al.

    Perinatal fluoxetine increases hippocampal neurogenesis and reverses the lasting effects of pre-gestational stress on serum corticosterone, but not on maternal behavior, in the rat dam

    Behav. Brain Res.

    (2018)
  • A.R. Gobinath et al.

    Voluntary running influences the efficacy of fluoxetine in a model of postpartum depression

    Neuropharmacology

    (2018)
  • A.D. Green et al.

    Role of estradiol withdrawal in ‘anhedonic’ sucrose consumption: a model of postpartum depression

    Physiol. Behav.

    (2009)
  • A.D. Green et al.

    Adult hippocampal cell proliferation is suppressed with estrogen withdrawal after a hormone-simulated pregnancy

    Horm. Behav.

    (2008)
  • M.D. Greicius et al.

    Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus

    Biol. Psychiatry

    (2007)
  • R. Haapakoski et al.

    Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder

    Brain. Behav. Immun.

    (2015)
  • A. Haim et al.

    The effects of gestational stress and selective serotonin reuptake inhibitor antidepressant treatment on structural plasticity in the postpartum brain – a translational model for postpartum depression

    Horm. Behav.

    (2016)
  • V. Hendrick et al.

    Hormonal changes in the postpartum and implications for postpartum depression

    Psychosomatics

    (1998)
  • M.E. Addis

    Gender and depression in men

    Clin. Psychol. Sci. Pract.

    (2008)
  • H. Akil et al.

    Treatment resistant depression: a multi-scale, systems biology approach

    Neurosci. Biobehav. Rev.

    (2017)
  • M. Altemus et al.

    Phenotypic differences between pregnancy-onset and postpartum-onset major depressive disorder

    J. Clin. Psychiatry

    (2012)
  • American Psychiatric Association

    DSM-5

    Am. J. Psychiatry

    (2013)
  • C. Anacker et al.

    Adult hippocampal neurogenesis and cognitive flexibility — linking memory and mood

    Nat. Rev. Neurosci.

    (2017)
  • J. Angst et al.

    Gender differences in depression: Epidemiological findings from the European DEPRES I and II studies

    Eur. Arch. Psychiatry Clin. Neurosci.

    (2002)
  • L. Appleby et al.

    A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression

    BMJ

    (1997)
  • T.L. Bale

    Stress sensitivity and the development of affective disorders

    Horm. Behav.

    (2006)
  • A.M. Bao et al.

    Sexual differentiation of the human brain: relation to gender identity, sexual orientation and neuropsychiatric disorders

    Front. Neuroendocrinol.

    (2011)
  • C. Berlanga et al.

    Different gender response to serotonergic and noradrenergic antidepressants. A comparative study of the efficacy of citalopram and reboxetine

    J. Affect. Disord.

    (2006)
  • J.M. Bessa et al.

    The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling

    Mol. Psychiatry

    (2009)
  • K.L. Bigos et al.

    Sex differences in the pharmacokinetics and pharmacodynamics of antidepressants: an updated review

    Gend. Med.

    (2009)
  • B. Birur et al.

    Sex differences in the peripheral immune system in patients with depression

    Front. Psychiatry

    (2017)
  • A. Bjørnebekk et al.

    The antidepressant effect of running is associated with increased hippocampal cell proliferation

    Int. J. Neuropsychopharmacol.

    (2005)
  • A. Bjørnebekk et al.

    Running has differential effects on NPY, opiates, and cell proliferation in an animal model of depression and controls

    Neuropsychopharmacology

    (2006)
  • C. Blanco et al.

    Epidemiology of major depression with atypical features: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

    J. Clin. Psychiatry

    (2012)
  • M. Bloch et al.

    The effect of sertraline add-on to brief dynamic psychotherapy for the treatment of postpartum depression

    J. Clin. Psychiatry

    (2012)
  • M. Bloch et al.

    Effects of gonadal steroids in women with a history of postpartum depression

    Am. J. Psychiatry

    (2000)
  • Cited by (222)

    View all citing articles on Scopus
    View full text